An Intervention Program to Control Diabetes

Study to evaluate the effectiveness of a structured intervention to improve diabetes control.

Completed

Looking for future studies?

Key information

Conditions

Diabetes Mellitus, Type 2 Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Huandong Hospital

Shanghai, China

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

informed consent
18-70 adults
Type 2 Diabetes
Males and non-pregnant females

Exclusion criteria

Use of exogenous insulin for glucose control
Use of medications or supplements for weight loss
Advanced diabetes complications
Recent history of cardiovascular event

Treatment and study plan

daily enteral nutritional product and/or behavioral changes

Other

Primary outcomes

HbA1c, Fasting blood glucose,blood pressure, weight loss

Time frame: 24 weeks

Sponsors and collaborators

Lead sponsor

Abbott Nutrition

Industry

Registry information

Important dates

Study start: 2005
First posted: Oct 15, 2007
Registry last updated: Oct 15, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed